Thromboembolic disease in COVID-19 patients: A brief narrative review

被引：0
作者：
Samhati Mondal
Ashley L. Quintili
Kunal Karamchandani
Somnath Bose
机构：
[1] University of Maryland School of Medicine,Department of Anesthesiology
[2] Penn State Health Milton S. Hershey Medical Center,Department of Pharmacy
[3] Penn State Health Milton S. Hershey Medical Center,Department of Anesthesiology and Perioperative Medicine
[4] Beth Israel Deaconess Medical Center,Department of Anesthesiology, Critical Care and Pain Medicine
[5] Harvard Medical School,undefined
来源：
Journal of Intensive Care | / 8卷
关键词：
COVID-19; thrombosis; thromboembolism; SARS-CoV2; management; coagulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Corona virus 2 (SARS-CoV2/ Severe Acute Respiratory Syndrome Corona Virus 2) infection has emerged as a global health crisis. Incidence of thromboembolic disease is reported to be high in SARS-CoV2 disease and is seen in a multitude of organ systems ranging from cutaneous thrombosis to pulmonary embolism, stroke or coronary thrombosis sometimes with catastrophic outcomes. Evidence points towards a key role of thromboembolism, hypercoagulability and over production of proinflammatory cytokines mimicking a “cytokine storm” which leads to multiorgan failure. This brief narrative review highlights the pathophysiology and risk factors of thromboembolic disease and provides a framework for management of anticoagulation based on the current evidence.
引用
收藏
相关论文
共 146 条
[1]  
Meduri GU(1995)Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome Chest 108 1303-1314
[2]  
Kohler G(2020)Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J Thromb Haemost 18 844-847
[3]  
Headley S(2020)Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Thromb Res 191 145-147
[4]  
Tolley E(2020)Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis Thromb Res 191 148-150
[5]  
Stentz F(2013)Biomarkers of sepsis Crit Rev Clin Lab Sci 50 23-36
[6]  
Postlethwaite A(2018)Hemostasis based on a novel 'two-path unifying theory' and classification of hemostatic disorders Blood Coagul Fibrinolysis 29 573-584
[7]  
Tang N(2019)Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease Thromb J 17 10-83
[8]  
Li D(2019)The stimulation of thrombosis by hypoxia Thromb Res 181 77-13
[9]  
Wang X(2020)A pathological report of three COVID-19 cases by minimally invasive autopsies Zhonghua Bing Li Xue Za Zhi 49 E009-97
[10]  
Sun Z(2020)Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases Transl Res 220 1-14
12345678910